PureTech Health PLC ADR (PRTCY)

Currency in USD
14.90
+0.67(+4.71%)
Closed·
PRTCY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.9014.90
52 wk Range
13.9319.92
Key Statistics
Prev. Close
14.9
Open
14.9
Day's Range
14.9-14.9
52 wk Range
13.93-19.92
Volume
102
Average Volume (3m)
4.43K
1-Year Change
-17.2222%
Book Value / Share
1.59
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PRTCY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

PureTech Health PLC ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

PureTech Health PLC ADR Earnings Call Summary for H2/2025

  • PureTech Health posted $110.1M net loss in FY2025 vs. $27.8M income in 2024; revenue fell 2.1% to $4.7M amid operational restructuring.
  • Operating loss improved 27.6% to $98.5M; cash position declined 24.5% YoY to $277.1M, with operational runway extending through 2028.
  • Company announced voluntary Nasdaq delisting while maintaining London Stock Exchange listing to reduce costs and streamline operations.
  • Stock dropped 2.98% to $17.60 in pre-market trading despite 9% YTD gains; analysts set $46 price target suggesting significant upside potential.
  • CEO emphasized strategic focus on capital efficiency and investments in founded entities like Celea Therapeutics and Gallop Oncology for growth.
Last Updated: 2026-04-29, 10:34 a/m
Read Full Transcript

Earnings

Latest Release
Sep 22, 2026
EPS / Forecast
0.27 / --
Revenue / Forecast
3.56M / 24.8M
EPS Revisions
Last 90 days

PRTCY Income Statement

Compare PRTCY to Peers and Sector

Metrics to compare
PRTCY
Peers
Sector
Relationship
P/E Ratio
174.3x13.1x−0.3x
PEG Ratio
−1.870.080.00
Price/Book
1.0x4.0x2.6x
Price / LTM Sales
57.9x4.3x2.9x
Upside (Analyst Target)
208.7%64.4%64.3%
Fair Value Upside
Unlock22.6%10.0%Unlock

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases and LYT-200, a fully human IgG4 monoclonal antibody. The company also develops SPT-300, a Glyphed oral prodrug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development and oral therapies based on defined bacterial consortia that is in phase 3 clinical stage. PureTech Health plc was incorporated in 2015 and is based in Boston, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
87.50M35.69%1.25B
Other Institutional Investors
125.40M51.14%1.78B
Public Companies & Retail Investors
32.29M13.17%459.47M
Total
245.18M100.00%3.49B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Invesco Ltd.16.73%41,011,890583,599
Invesco Perpetual UK Investment Series ICVC - Invesco UK Equity High Income Fund (UK)11.50%28,188,790401,126

People Also Watch

2.870
IVA
0.00%
67.55
PCVX
+1.12%
0.0200
OTLC
+1.01%
23.67
NRIX
+6.96%
46.67
ANAB
+2.37%

FAQ

What Is the PureTech Health ADR (PRTCY) Stock Price Today?

The PureTech Health ADR stock price today is 14.90 USD.

What Stock Exchange Does PureTech Health ADR Trade On?

PureTech Health ADR is listed and trades on the OTC Markets.

What Is the Stock Symbol for PureTech Health ADR?

The stock symbol for PureTech Health ADR is "PRTCY."

What Is the PureTech Health ADR Market Cap?

As of today, PureTech Health ADR market cap is 368.24M USD.

What Is PureTech Health ADR's Earnings Per Share (TTM)?

The PureTech Health ADR EPS (TTM) is 0.01.

When Is the Next PureTech Health ADR Earnings Date?

PureTech Health ADR will release its next earnings report on Dec 02, 2026.

From a Technical Analysis Perspective, Is PRTCY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has PureTech Health ADR Stock Split?

PureTech Health ADR has split 0 times.

How Many Employees Does PureTech Health ADR Have?

PureTech Health ADR has 90 employees.

What is the current trading status of PureTech Health ADR (PRTCY)?

As of Oct 15, 2026, PureTech Health ADR (PRTCY) is trading at a price of 14.90 USD, with a previous close of 14.90 USD. The stock has fluctuated within a day range of 14.90 USD to 14.90 USD, while its 52-week range spans from 13.93 USD to 19.92 USD.

What Is the PRTCY After Hours Price?

PRTCY's last after hours stock price is 17.41 USD, the stock has decreased by 0.68, or 4.06%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.